NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.689
-0.020 (-2.81%)
Nov 21, 2024, 11:28 AM EST - Market open
NovaBay Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 1 | 4 | 17 | 29 | 18 | |
| Market Cap Growth | 77.51% | -66.44% | -76.55% | -41.88% | 63.09% | 35.23% | |
| Enterprise Value | 4 | 3 | 3 | 8 | 16 | 14 | |
| Last Close Price | 0.71 | 7.14 | 68.25 | 461.34 | 853.83 | 784.00 | |
| PS Ratio | 0.07 | 0.09 | 0.28 | 1.66 | 2.93 | 2.71 | |
| PB Ratio | 3.25 | 0.40 | 0.38 | 1.66 | 2.36 | 18.35 | |
| P/TBV Ratio | 3.16 | 0.98 | 0.80 | - | 2.36 | 18.35 | |
| EV/Sales Ratio | 0.29 | 0.19 | 0.20 | 0.79 | 1.65 | 2.14 | |
| Debt / Equity Ratio | 1.18 | 0.83 | 0.19 | 0.05 | 0.04 | 4.16 | |
| Asset Turnover | 1.66 | 1.16 | 0.71 | 0.52 | 0.75 | 0.64 | |
| Inventory Turnover | 2.92 | 2.07 | 1.83 | 1.76 | 7.22 | 4.50 | |
| Quick Ratio | 0.75 | 0.91 | 1.72 | 2.66 | 4.61 | 1.41 | |
| Current Ratio | 1.15 | 1.67 | 2.66 | 3.83 | 5.03 | 1.65 | |
| Return on Equity (ROE) | -273.79% | -139.03% | -102.37% | -51.79% | -166.11% | -325.90% | |
| Return on Assets (ROA) | -41.80% | -24.59% | -23.78% | -28.25% | -30.36% | -57.09% | |
| Return on Capital (ROIC) | -56.53% | -33.53% | -41.17% | -47.05% | -45.03% | -117.82% | |
| Earnings Yield | -478.21% | -723.74% | -267.27% | -34.41% | -37.91% | -54.09% | |
| FCF Yield | -136.81% | -311.57% | -170.47% | -54.62% | -16.30% | -44.51% | |
| Buyback Yield / Dilution | -1605.55% | -161.80% | -29.11% | -24.43% | -62.08% | -26.87% | |
| Total Shareholder Return | -1605.55% | -161.80% | -29.11% | -24.43% | -62.08% | -26.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.